Concise review: Colorectal cancer stem cells

Stem Cells

Volumn 30, Issue 3, 2012, Pages 363-371

  Vaiopoulos, Aristides G ^a   Kostakis, Ioannis D ^a   Koutsilieris, Michael ^a   Papavassiliou, Athanasios G ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Colorectal cancer; Epithelial to mesenchymal transition; Metastasis; Microenvironment; Stem cells

Indexed keywords

ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE; BETA CATENIN; BETA1 INTEGRIN; BONE MORPHOGENETIC PROTEIN; CD133 ANTIGEN; CD24 ANTIGEN; CD44V ANTIGEN; FORKHEAD TRANSCRIPTION FACTOR; G PROTEIN COUPLED RECEPTOR 54; GAMMA SECRETASE; INTERLEUKIN 1; INTERLEUKIN 6; LEUCINE; OCTAMER TRANSCRIPTION FACTOR 4; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PLATELET DERIVED GROWTH FACTOR; TELOMERASE REVERSE TRANSCRIPTASE; TRANSCRIPTION FACTOR SOX2; TUMOR NECROSIS FACTOR ALPHA; WNT PROTEIN; TUMOR MARKER;

CANCER STEM CELL; CARCINOGENESIS; CELL DIFFERENTIATION; CELL PROLIFERATION; CIRCULATING TUMOR CELL; COLORECTAL CANCER; DNA DAMAGE; DNA REPAIR; EPITHELIUM CELL; HEMATOPOIETIC SYSTEM; LEUKEMIA VIRUS; MICROENVIRONMENT; REVIEW; TUMOR GROWTH; ANIMAL; CELL TRANSFORMATION; COLORECTAL TUMOR; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION; STEM CELL NICHE;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; COLORECTAL NEOPLASMS; EPITHELIAL-MESENCHYMAL TRANSITION; HUMANS; NEOPLASTIC STEM CELLS; SIGNAL TRANSDUCTION; STEM CELL NICHE; TUMOR MARKERS, BIOLOGICAL;

EID: 84857491952     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.1031     Document Type: Review

References (98)

1. Jemal A, Bray F, Center MM et al. Global cancer statistics. CA Cancer J Clin 2011;61:69-90.
2. Markowitz SD, Bertagnolli MM. Molecular origins of cancer: Molecular basis of colorectal cancer. N Engl J Med 2009;361:2449-2460.
3. Lampropoulos P, Zizi-Sermpetzoglou A, Rizos S et al. TGF-beta signalling in colon carcinogenesis. Cancer Lett 2012;314:1-7.
4. Huang EH, Wicha MS. Colon cancer stem cells: Implications for prevention and therapy. Trends Mol Med 2008;14:503-509.
5. Ricci-Vitiani L, Fabrizi E, Palio E et al. Colon cancer stem cells. J Mol Med (Berl) 2009;87:1097-1104.
6. Boman BM, Huang E. Human colon cancer stem cells: A new paradigm in gastrointestinal oncology. J Clin Oncol 2008;26:2828-2838.
7. Medema JP, Vermeulen L. Microenvironmental regulation of stem cells in intestinal homeostasis and cancer. Nature 2011;474:318-326.
8. Vries RG, Huch M, Clevers H. Stem cells and cancer of the stomach and intestine. Mol Oncol 2010;4:373-384.
9. Papailiou J, Bramis KJ, Gazouli M et al. Stem cells in colon cancer. A new era in cancer theory begins. Int J Colorectal Dis 2011;26:1-11.
10. Todaro M, Francipane MG, Medema JP et al. Colon cancer stem cells: Promise of targeted therapy. Gastroenterology 2010;138:2151-2162.
11. Dalerba P, Cho RW, Clarke MF. Cancer stem cells: Models and concepts. Annu Rev Med 2007;58:267-284. (Pubitemid 46706514)
12. Davies EJ, Marsh V, Clarke AR. Origin and maintenance of the intestinal cancer stem cell. Mol Carcinog 2011;50:254-263.
13. Lopez-Garcia C, Klein AM, Simons BD et al. Intestinal stem cell replacement follows a pattern of neutral drift. Science 2010;330:822-825.
14. Tian H, Biehs B, Warming S et al. A reserve stem cell population in small intestine renders Lgr5-positive cells dispensable. Nature 2011;478:255-259.
15. van der Flier LG, van Gijn ME, Hatzis P et al. Transcription factor achaete scute-like 2 controls intestinal stem cell fate. Cell 2009;136:903-912.
16. Potten CS, Gandara R, Mahida YR et al. The stem cells of small intestinal crypts: Where are they? Cell Prolif 2009;42:731-750.
17. Willis ND, Przyborski SA, Hutchison CJ et al. Colonic and colorectal cancer stem cells: Progress in the search for putative biomarkers. J Anat 2008;213:59-65. (Pubitemid 352044396)
18. Haegebarth A, Clevers H. Wnt signaling, Lgr5, and stem cells in the intestine and skin. Am J Pathol 2009;174:715-721.
19. Simons BD, Clevers H. Stem cell self-renewal in intestinal crypt. Exp Cell Res 2011;317:2719-2724.
20. Zhu L, Gibson P, Currle DS et al. Prominin 1 marks intestinal stem cells that are susceptible to neoplastic transformation. Nature 2009;457:603-607.
21. Barker N, van Es JH, Kuipers J et al. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 2007;449:1003-1007. (Pubitemid 350014593)
22. Sato T, Vries RG, Snippert HJ et al. Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature 2009;459:262-265.
23. Huang EH, Hynes MJ, Zhang T et al. Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis. Cancer Res 2009;69:3382-3389.
24. Frank NY, Schatton T, Frank MH. The therapeutic promise of the cancer stem cell concept. J Clin Invest 2010;120:41-50.
25. Lobo NA, Shimono Y, Qian D et al. The biology of cancer stem cells. Annu Rev Cell Dev Biol 2007;23:675-699.
26. Fabian A, Barok M, Vereb G et al. Die hard: Are cancer stem cells the Bruce Willises of tumor biology? Cytometry A 2009;75:67-74.
27. Visvader JE, Lindeman GJ. Stem cells and cancer - The promise and puzzles. Mol Oncol 2010;4:369-372.
28. Visvader JE, Lindeman GJ. Cancer stem cells in solid tumours: Accumulating evidence and unresolved questions. Nat Rev Cancer 2008;8:755-768.
29. Lugli A, Iezzi G, Hostettler I et al. Prognostic impact of the expression of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM, and ALDH1 in colorectal cancer. Br J Cancer 2010;103:382-390.
30. Houghton J, Stoicov C, Nomura S et al. Gastric cancer originating from bone marrow-derived cells. Science 2004;306:1568-1571. (Pubitemid 39564955)
31. Abdul Khalek FJ, Gallicano GI, Mishra L. Colon cancer stem cells. Gastrointest Cancer Res 2010(suppl 1):16-23.
32. Fevr T, Robine S, Louvard D et al. Wnt/beta-catenin is essential for intestinal homeostasis and maintenance of intestinal stem cells. Mol Cell Biol 2007;27:7551-7559. (Pubitemid 350033660)
33. Hardwick JC, Kodach LL, Offerhaus GJ et al. Bone morphogenetic protein signalling in colorectal cancer. Nat Rev Cancer 2008;8:806-812.
34. Brittan M, Wright NA. Stem cell in gastrointestinal structure and neoplastic development. Gut 2004;53:899-910. (Pubitemid 38662143)
35. Burness ML, Sipkins DA. The stem cell niche in health and malignancy. Semin Cancer Biol 2010;20:107-115.
36. Vermeulen L, De Sousa EMF, van der Heijden M et al. Wnt activity defines colon cancer stem cells and is regulated by the microenvironment. Nat Cell Biol 2010;12:468-476.
37. Monteiro J, Fodde R. Cancer stemness and metastasis: Therapeutic consequences and perspectives. Eur J Cancer 2010;46:1198-1203.
38. Takaku K, Oshima M, Miyoshi H et al. Intestinal tumorigenesis in compound mutant mice of both Dpc4 (Smad4) and Apc genes. Cell 1998;92:645-656. (Pubitemid 28141513)
39. Bissell MJ, Labarge MA. Context, tissue plasticity, and cancer: Are tumor stem cells also regulated by the microenvironment? Cancer Cell 2005;7:17-23. (Pubitemid 40126379)
40. Chaffer CL, Weinberg RA. A perspective on cancer cell metastasis. Science 2011;331:1559-1564.
41. Sleeman JP, Nazarenko I, Thiele W. Do all roads lead to Rome? Routes to metastasis development. Int J Cancer 2011;128:2511-2526.
42. Dittmar T, Heyder C, Gloria-Maercker E et al. Adhesion molecules and chemokines: The navigation system for circulating tumor (stem) cells to metastasize in an organ-specific manner. Clin Exp Metastasis 2008;25:11-32. (Pubitemid 351191223)
43. Brooks SA, Lomax-Browne HJ, Carter TM et al. Molecular interactions in cancer cell metastasis. Acta Histochem 2010;112:3-25.
44. Singh A, Settleman J. EMT, cancer stem cells and drug resistance: An emerging axis of evil in the war on cancer. Oncogene 2010;29:4741-4751.
45. Kong D, Li Y, Wang Z et al. Cancer stem cells and epithelial-to- mesenchymal transition (EMT)-phenotypic cells: Are they cousins or twins? Cancers (Basel) 2011;3:716-729.
46. Dalerba P, Clarke MF. Cancer stem cells and tumor metastasis: First steps into uncharted territory. Cell Stem Cell 2007;1:241-242. (Pubitemid 47355332)
47. Gupta PB, Chaffer CL, Weinberg RA. Cancer stem cells: Mirage or reality? Nat Med 2009;15:1010-1012.
48. Rosen JM, Jordan CT. The increasing complexity of the cancer stem cell paradigm. Science 2009;324:1670-1673.
49. Hoon DS, Ferris R, Tanaka R et al. Molecular mechanisms of metastasis. J Surg Oncol 2011;103:508-517.
50. Sun YF, Yang XR, Zhou J et al. Circulating tumor cells: Advances in detection methods, biological issues, and clinical relevance. J Cancer Res Clin Oncol 2011;137:1151-1173.
51. Iinuma H, Watanabe T, Mimori K et al. Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with Dukes' stage B and C colorectal cancer. J Clin Oncol 2011;29:1547-1555.
52. Gazzaniga P, Gradilone A, Petracca A et al. Molecular markers in circulating tumour cells from metastatic colorectal cancer patients. J Cell Mol Med 2010;14:2073-2077.
53. Salama P, Platell C. Colorectal cancer stem cells. ANZ J Surg 2009;79:697-702.
54. Rajasekhar VK, Dalerba P, Passegue E et al. The 5th International Society for Stem Cell Research (ISSCR) Annual Meeting, June 2007. Stem Cells 2008;26:292-298.
55. Botchkina IL, Rowehl RA, Rivadeneira DE et al. Phenotypic subpopulations of metastatic colon cancer stem cells: Genomic analysis. Cancer Genomics Proteomics 2009;6:19-29.
56. Cammareri P, Lombardo Y, Francipane MG et al. Isolation and culture of colon cancer stem cells. Methods Cell Biol 2008;86:311-324.
57. Dou J, Gu N. Emerging strategies for the identification and targeting of cancer stem cells. Tumour Biol 2010;31:243-253.
58. Ricci-Vitiani L, Lombardi DG, Pilozzi E et al. Identification and expansion of human colon-cancer-initiating cells. Nature 2007;445:111-115. (Pubitemid 46067311)
59. O'Brien CA, Pollett A, Gallinger S et al. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 2007;445:106-110. (Pubitemid 46067310)
60. Horst D, Kriegl L, Engel J et al. CD133 expression is an independent prognostic marker for low survival in colorectal cancer. Br J Cancer 2008;99:1285-1289.
61. Horst D, Kriegl L, Engel J et al. CD133 and nuclear beta-catenin: The marker combination to detect high risk cases of low stage colorectal cancer. Eur J Cancer 2009;45:2034-2040.
62. Kojima M, Ishii G, Atsumi N et al. Immunohistochemical detection of CD133 expression in colorectal cancer: A clinicopathological study. Cancer Sci 2008;99:1578-1583.
63. Horst D, Scheel SK, Liebmann S et al. The cancer stem cell marker CD133 has high prognostic impact but unknown functional relevance for the metastasis of human colon cancer. J Pathol 2009;219:427-434.
64. Artells R, Moreno I, Diaz T et al. Tumour CD133 mRNA expression and clinical outcome in surgically resected colorectal cancer patients. Eur J Cancer 2010;46:642-649.
65. Huh JW, Park YS, Lee JH et al. CD133 mRNA expression and microsatellite instability in colorectal carcinoma. J Surg Oncol 2010;102:765-770.
66. Wang Q, Chen ZG, Du CZ et al. Cancer stem cell marker CD133+ tumour cells and clinical outcome in rectal cancer. Histopathology 2009;55:284-293.
67. Elsaba TM, Martinez-Pomares L, Robins AR et al. The stem cell marker CD133 associates with enhanced colony formation and cell motility in colorectal cancer. PLoS One 2010;19:e10714.
68. Kemper K, Sprick MR, de Bree M et al. The AC133 epitope, but not the CD133 protein, is lost upon cancer stem cell differentiation. Cancer Res 2010;70:719-729.
69. Osmond TL, Broadley KW, McConnell MJ. Glioblastoma cells negative for the anti-CD133 antibody AC133 express a truncated variant of the CD133 protein. Int J Mol Med 2010;5:883-888.
70. Shmelkov SV, Butler JM, Hooper AT et al. CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors. J Clin Invest 2008;118:2111-2120. (Pubitemid 351872330)
71. Du L, Wang H, He L et al. CD44 is of functional importance for colorectal cancer stem cells. Clin Cancer Res 2008;14:6751-6760.
72. Huh JW, Kim HR, Kim YJ et al. Expression of standard CD44 in human colorectal carcinoma: Association with prognosis. Pathol Int 2009;59:241-246.
73. Haraguchi N, Ohkuma M, Sakashita H et al. CD133+CD44+ population efficiently enriches colon cancer initiating cells. Ann Surg Oncol 2008;15:2927-2933.
74. Dalerba P, Dylla SJ, Park IK et al. Phenotypic characterization of human colorectal cancer stem cells. Proc Natl Acad Sci USA 2007;104:10158-10163. (Pubitemid 47175279)
75. Chu P, Clanton DJ, Snipas TS et al. Characterization of a subpopulation of colon cancer cells with stem cell-like properties. Int J Cancer 2009;124:1312-1321.
76. Todaro M, Perez Alea M, Scopelliti A et al. IL-4-mediated drug resistance in colon cancer stem cells. Cell Cycle 2008;7:309-313. (Pubitemid 351366493)
77. Vermeulen L, Todaro M, de Sousa Mello F et al. Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity. Proc Natl Acad Sci USA 2008;105:13427-13432.
78. Choi D, Lee HW, Hur KY et al. Cancer stem cell markers CD133 and CD24 correlate with invasiveness and differentiation in colorectal adenocarcinoma. World J Gastroenterol 2009;15:2258-2264.
79. Weichert W, Denkert C, Burkhardt M et al. Cytoplasmic CD24 expression in colorectal cancer independently correlates with shortened patient survival. Clin Cancer Res 2005;11:6574-6581. (Pubitemid 41338997)
80. Yeung TM, Gandhi SC, Wilding JL et al. Cancer stem cells from colorectal cancer-derived cell lines. Proc Natl Acad Sci USA 2010;107:3722-3727.
81. Fan LF, Dong WG, Jiang CQ et al. Expression of putative stem cell genes Musashi-1 and beta1-integrin in human colorectal adenomas and adenocarcinomas. Int J Colorectal Dis 2010;25:17-23.
82. Weichert W, Knosel T, Bellach J et al. ALCAM/CD166 is overexpressed in colorectal carcinoma and correlates with shortened patient survival. J Clin Pathol 2004;57:1160-1164. (Pubitemid 39486521)
83. Becker L, Huang Q, Mashimo H. Immunostaining of Lgr5, an intestinal stem cell marker, in normal and premalignant human gastrointestinal tissue. ScientificWorldJournal 2008;8:1168-1176.
84. Barker N, Ridgway RA, van Es JH et al. Crypt stem cells as the cells-of-origin of intestinal cancer. Nature 2009;457:608-611.
85. Kleist B, Xu L, Li G et al. Expression of the adult intestinal stem cell marker Lgr5 in the metastatic cascade of colorectal cancer. Int J Clin Exp Pathol 2011;4:327-335.
86. Takahashi H, Ishii H, Nishida N et al. Significance of Lgr5(+ve) cancer stem cells in the colon and rectum. Ann Surg Oncol 2011;18:1166-1174.
87. Pang R, Law WL, Chu AC et al. A subpopulation of CD26+ cancer stem cells with metastatic capacity in human colorectal cancer. Cell Stem Cell 2010;6:603-615.
88. Chen Y, Orlicky DJ, Matsumoto A et al. Aldehyde dehydrogenase 1B1 (ALDH1B1) is a potential biomarker for human colon cancer. Biochem Biophys Res Commun 2011;405:173-179.
89. Deng S, Yang X, Lassus H et al. Distinct expression levels and patterns of stem cell marker, aldehyde dehydrogenase isoform 1 (ALDH1), in human epithelial cancers. PLoS One 2010;5:e10277.
90. Carpentino JE, Hynes MJ, Appelman HD et al. Aldehyde dehydrogenase- expressing colon stem cells contribute to tumorigenesis in the transition from colitis to cancer. Cancer Res 2009;69:8208-8215.
91. Saiki Y, Ishimaru S, Mimori K et al. Comprehensive analysis of the clinical significance of inducing pluripotent stemness-related gene expression in colorectal cancer cells. Ann Surg Oncol 2009;16:2638-2644.
92. Ong CW, Kim LG, Kong HH et al. CD133 expression predicts for non-response to chemotherapy in colorectal cancer. Mod Pathol 2010;23:450-457.
93. Saigusa S, Tanaka K, Toiyama Y et al. Correlation of CD133, OCT4, and SOX2 in rectal cancer and their association with distant recurrence after chemoradiotherapy. Ann Surg Oncol 2009;16:3488-3498.
94. Navarro-Alvarez N, Kondo E, Kawamoto H et al. Isolation and propagation of a human CD133(-) colon tumor-derived cell line with tumorigenic and angiogenic properties. Cell Transplant 2010;19:865-877.
95. Massard C, Deutsch E, Soria JC. Tumour stem cell-targeted treatment: Elimination or differentiation. Ann Oncol 2006;17:1620-1624. (Pubitemid 44680880)
96. Dylla SJ, Beviglia L, Park IK et al. Colorectal cancer stem cells are enriched in xenogeneic tumors following chemotherapy. PLoS One 2008;3:e2428.
97. Schatton T, Frank NY, Frank MH. Identification and targeting of cancer stem cells. Bioessays 2009;31:1038-1049.
98. Todaro M, Alea MP, Di Stefano AB et al. Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4. Cell Stem Cell 2007;4:389-402. (Pubitemid 47506537)